# Effects of Short-term Growth Hormone in HIV-infected Patients

> **NCT00795210** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 25 (actual)

## Conditions studied

- HIV Lipodystrophy

## Interventions

- **DRUG:** Growth hormone
- **DRUG:** Growth Hormone Releasing Hormone

## Key facts

- **NCT ID:** NCT00795210
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795210, "Effects of Short-term Growth Hormone in HIV-infected Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00795210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
